Literature DB >> 9776042

Changes in intestinal alkaline phosphatase isoforms in healthy subjects bearing the blood group secretor and non-secretor.

M Matsushita1, T Irino, T Stigbrand, T Nakajima, T Komoda.   

Abstract

We found the high molecular mass intestinal alkaline phosphatase (HIAP) and normal molecular mass intestinal alkaline phosphatase (NIAP) in serum at fasting and after fatty meal by use of 6.0% polyacrylamide gel electrophoresis (PAGE) in the presence of 1% Triton X-100. HIAP only appeared in serum of Lewis blood group secretors ¿Le(a-b+)¿, and HIAP levels were dependent on ABO blood groups. Among the secretors, the highest activities of HIAP in fasting serum were observed in subjects with blood groups O and B (8.6+/-1.4 U/1; mean+/-SD) and the lowest activities were associated with blood group A (0.7+/-0.2 U/1; mean+/-SD), and the HIAP activities did not change after fatty meal. In contrast, NIAP was present in the serum of both secretors and non-secretors regardless of ABO blood group. Trace amounts of NIAP remained in fasting serum; however serum NIAP activities rose sharply after fatty meal. The remaining ratios of NIAP activity at fasting and 9 h after fatty meal of secretors were approximately the same as those of non-secretors. The electrophoretic mobility on PAGE or the apparent molecular mass estimated by gel filtration of serum NIAP in secretors was slightly different from that in non-secretors. In addition, HIAP can be normalized to NIAP on PAGE in the absence of Triton X-100, and the electrophoretic mobility of normalized-NIAP was identical to that of original NIAP in secretors. Accordingly, it can be concluded that the structure of serum NIAP in the secretor was different from that in the non-secretor, because HIAP is only formed by serum NIAP in the secretor. These results suggest that differences in serum NIAP in the secretor and the non-secretor may be closely related to the appearance of IAP in the circulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9776042     DOI: 10.1016/s0009-8981(98)00102-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  High-molecular intestinal alkaline phosphatase in chronic liver diseases.

Authors:  Kinue Ooi; Katsuya Shiraki; Yoshitaka Morishita; Tsutomu Nobori
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

2.  Alkaline Phosphatase Pathophysiology with Emphasis on the Seldom-Discussed Role of Defective Elimination in Unexplained Elevations of Serum ALP - A Case Report and Literature Review.

Authors:  Michael D Levitt; Sophie M Hapak; David G Levitt
Journal:  Clin Exp Gastroenterol       Date:  2022-03-15

3.  Interaction of genetic markers associated with serum alkaline phosphatase levels in the Japanese population.

Authors:  Masatoshi Masuda; Kayo Okuda; Daisuke D Ikeda; Haretsugu Hishigaki; Tsutomu Fujiwara
Journal:  Hum Genome Var       Date:  2015-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.